HDL cholesterol and bone mineral density: Is there a genetic link?

Bone

Volumn 50, Issue 2, 2012, Pages 525-533

  Ackert Bicknell, Cheryl L ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

Bone mass; Correlation studies; Genetics; High density lipoprotein cholesterol; Pleiotropy

Indexed keywords

ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN K GROUP;

APOPTOSIS; ARTICLE; BONE DENSITY; CELL MATURATION; CHOLESTEROL BLOOD LEVEL; ENVIRONMENTAL FACTOR; ETHNICITY; EXPERIMENTAL MOUSE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC REGULATION; GENETIC TRAIT; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; PHENOTYPE; PLEIOTROPY; QUANTITATIVE TRAIT LOCUS; SEX DIFFERENCE; WOMEN'S HEALTH;

ANIMALS; BONE DENSITY; CHOLESTEROL, HDL; ESTROGENS; GENE-ENVIRONMENT INTERACTION; GENETIC PLEIOTROPY; HUMANS; OSTEOBLASTS;

EID: 84855863646     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.07.002     Document Type: Article

References (127)

1. Elkeles A. Studies on osteoporosis. Br Med J 1968, 4:582.
2. Anderson J.B., Barnett E., Nordin B.E. The relation between osteoporosis and aortic calcification. Br J Radiol 1964, 37:910-912.
3. Heidenreich P.A., Trogdon J.G., Khavjou O.A., Butler J., Dracup K., Ezekowitz M.D., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123:933-944.
4. Bone Health and Osteoporosis: a Report of the Surgeon General 2004, Services USDoHaH, U.S. Department of Health and Human Services, Office of the Surgeon General, Rockville, MD.
5. Qi L., Shen H., Ordovas J.M. Hearts and bones. Nutr Metab Cardiovasc Dis 2003, 13:165-174.
6. Martinez-Ramirez M.J., Palma S., Martinez-Gonzalez M.A., Delgado-Martinez A.D., de la Fuente C., Delgado-Rodriguez M. Dietary fat intake and the risk of osteoporotic fractures in the elderly. Eur J Clin Nutr 2007, 61:1114-1120.
7. Sennerby U., Farahmand B., Ahlbom A., Ljunghall S., Michaelsson K. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 2007, 18:1355-1362.
8. Sennerby U., Melhus H., Gedeborg R., Byberg L., Garmo H., Ahlbom A., et al. Cardiovascular diseases and risk of hip fracture. JAMA 2009, 302:1666-1673.
9. Marcovitz P.A., Tran H.H., Franklin B.A., O'Neill W.W., Yerkey M., Boura J., et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 2005, 96:1059-1063.
10. Tanko L.B., Christiansen C., Cox D.A., Geiger M.J., McNabb M.A., Cummings S.R. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005, 20:1912-1920.
11. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977, 62:707-714.
12. Rye K.A., Bursill C.A., Lambert G., Tabet F., Barter P.J. The metabolism and anti-atherogenic properties of HDL. J Lipid Res 2009, 50(Suppl):S195-S200.
13. Jeon Y.K., Lee J.G., Kim S.S., Kim B.H., Kim S.J., Kim Y.K., et al. Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J 2011, 58:87-93.
14. Jeong I.K., Cho S.W., Kim S.W., Choi H.J., Park K.S., Kim S.Y., et al. Lipid profiles and bone mineral density in pre- and postmenopausal women in Korea. Calcif Tissue Int 2010, 87:507-512.
15. Choi H.S., Kim K.J., Kim K.M., Hur N.W., Rhee Y., Han D.S., et al. Relationship between visceral adiposity and bone mineral density in Korean adults. Calcif Tissue Int 2010, 87:218-225.
16. Park K.K., Kim S.J., Moon E.S. Association between bone mineral density and metabolic syndrome in postmenopausal Korean women. Gynecol Obstet Invest 2010, 69:145-152.
17. Hernandez J.L., Olmos J.M., Ramos C., Martinez J., de Juan J., Valero C., et al. Serum lipids and bone metabolism in Spanish men: the Camargo cohort study. Endocr J 2010, 57:51-60.
18. Buizert P.J., van Schoor N.M., Lips P., Deeg D.J., Eekhoff E.M. Lipid levels: a link between cardiovascular disease and osteoporosis?. J Bone Miner Res 2009, 24:1103-1109.
19. Sivas F., Alemdaroglu E., Elverici E., Kulug T., Ozoran K. Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. Rheumatol Int 2009, 29:885-890.
20. Sanlier N. The effect of body composition on blood lipids, leptin, bone mineral density, and nutrition in females. Saudi Med J 2008, 29:1636-1642.
21. Makovey J., Chen J.S., Hayward C., Williams F.M., Sambrook P.N. Association between serum cholesterol and bone mineral density. Bone 2009, 44:208-213.
22. D'Amelio P., Di Bella S., Tamone C., Ravazzoli M.G., Cristofaro M.A., Di Stefano M., et al. HDL cholesterol and bone mineral density in normal-weight postmenopausal women: is there any possible association?. Panminerva Med 2008, 50:89-96.
23. Dennison E.M., Syddall H.E., Aihie Sayer A., Martin H.J., Cooper C. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. QJM 2007, 100:297-303.
24. Bagger Y.Z., Rasmussen H.B., Alexandersen P., Werge T., Christiansen C., Tanko L.B. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?. Osteoporos Int 2007, 18:505-512.
25. Hsu Y.H., Venners S.A., Terwedow H.A., Feng Y., Niu T., Li Z., et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006, 83:146-154.
26. Cui L.H., Shin M.H., Chung E.K., Lee Y.H., Kweon S.S., Park K.S., et al. Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos Int 2005, 16:1975-1981.
27. Solomon D.H., Avorn J., Canning C.F., Wang P.S. Lipid levels and bone mineral density. Am J Med 2005, 118:1414.
28. Adami S., Braga V., Zamboni M., Gatti D., Rossini M., Bakri J., et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 2004, 74:136-142.
29. Wu L.Y., Yang T.C., Kuo S.W., Hsiao C.F., Hung Y.J., Hsieh C.H., et al. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res 2003, 29:317-325.
30. Yamaguchi T., Sugimoto T., Yano S., Yamauchi M., Sowa H., Chen Q., et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr J 2002, 49:211-217.
31. Lidfeldt J., Holmdahl L., Samsioe G., Nerbrand C., Nyberg P., Schersten B., et al. The influence of hormonal status and features of the metabolic syndrome on bone density: a population-based study of Swedish women aged 50 to 59years. The women's health in the Lund area study. Metabolism 2002, 51:267-270.
32. Walker M.D., Novotny R., Bilezikian J.P., Weaver C.M. Race and diet interactions in the acquisition, maintenance, and loss of bone. J Nutr 2008, 138:1256S-1260S.
33. Kuller L.H. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr Opin Lipidol 2004, 15:109-113.
34. Mendelsohn M.E., Karas R.H. Molecular and cellular basis of cardiovascular gender differences. Science 2005, 308:1583-1587.
35. Ebeling P.R., Atley L.M., Guthrie J.R., Burger H.G., Dennerstein L., Hopper J.L., et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996, 81:3366-3371.
36. Pietschmann P., Rauner M., Sipos W., Kerschan-Schindl K. Osteoporosis: an age-related and gender-specific disease-a mini-review. Gerontology 2009, 55:3-12.
37. Wells G., Tugwell P., Shea B., Guyatt G., Peterson J., Zytaruk N., et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002, 23:529-539.
38. Weissglas-Volkov D., Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res 2010, 51:2032-2057.
39. Ralston S., de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 2006, 20:2492-2506.
40. Ackert-Bicknell C.L., Demissie S., Marin de Evsikova C., Hsu Y.H., DeMambro V.E., Karasik D., et al. PPARG by dietary fat interaction influences bone mass in mice and humans. J Bone Miner Res 2008, 23:1398-1408.
41. Blanchet C., Giguere Y., Prud'homme D., Dumont M., Rousseau F., Dodin S. Association of physical activity and bone: influence of vitamin D receptor genotype. Med Sci Sports Exerc 2002, 34:24-31.
42. Kitamura I., Ando F., Koda M., Okura T., Shimokata H. Effects of the interaction between lean tissue mass and estrogen receptor alpha gene polymorphism on bone mineral density in middle-aged and elderly Japanese. Bone 2007, 40:1623-1629.
43. Grarup N., Andreasen C.H., Andersen M.K., Albrechtsen A., Sandbaek A., Lauritzen T., et al. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects. J Clin Endocrinol Metab 2008, 93:2294-2299.
44. Kao W.T., Yen Y.C., Lung F.W. The effects of beta2 adrenergic receptor gene polymorphism in lipid profiles. Lipids Health Dis 2008, 7:20.
45. Mukherjee M., Shetty K.R. Variations in high-density lipoprotein cholesterol in relation to physical activity and Taq 1B polymorphism of the cholesteryl ester transfer protein gene. Clin Genet 2004, 65:412-418.
46. Senti M., Elosua R., Tomas M., Sala J., Masia R., Ordovas J.M., et al. Physical activity modulates the combined effect of a common variant of the lipoprotein lipase gene and smoking on serum triglyceride levels and high-density lipoprotein cholesterol in men. Hum Genet 2001, 109:385-392.
47. Escola-Gil J.C., Jorba O., Julve-Gil J., Gonzalez-Sastre F., Ordonez-Llanos J., Blanco-Vaca F. Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis. Clin Chem 1999, 45:1567-1569.
48. Wescott D., Schulingkamp R., Slaughter H., Bounous D. High density lipoprotein (HDL) assay comparison in hamster, mouse, rat and monkey plasma. Clin Chem 2006, Accessed April 15, 2011. http://www.abstractsonline.com/viewer/?mkey=%7BFFEB1FEA-E733-491D-9BFE-DBB1C5939B0A%7D.
49. The Mouse Phenome Database. Accessed April 15, 2011.
50. Mahley R.W., Palaoglu K.E., Atak Z., Dawson-Pepin J., Langlois A.M., Cheung V., et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995, 36:839-859.
51. Thelle D.S., Forde O.H., Arnesen E. Distribution of high-density lipoprotein cholesterol according to age, sex, and ethnic origin: cardiovascular disease study in Finnmark 1977. J Epidemiol Community Health 1982, 36:243-247.
52. Li J.Z., Chen M.L., Wang S., Dong J., Zeng P., Hou L.W. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Chin Med J 2004, 117:163-167.
53. Goh V.H., Tong T.Y., Mok H.P., Said B. Differential impact of aging and gender on lipid and lipoprotein profiles in a cohort of healthy Chinese Singaporeans. Asian J Androl 2007, 9:787-794.
54. Petkov P.M., Ding Y., Cassell M.A., Zhang W., Wagner G., Sargent E.E., et al. An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res 2004, 14:1806-1811.
55. Chesler E., Miller D., Branstetter L., Galloway L., Jackson B., Philip V., et al. The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics. Mamm Genome 2008, 19:382-389.
56. Brodeur M.R., Brissette L., Falstrault L., Luangrath V., Moreau R. Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3. J Bone Miner Res 2008, 23:326-337.
57. Brodeur M.R., Brissette L., Falstrault L., Moreau R. HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death. J Cell Biochem 2008, 105:1374-1385.
58. Luegmayr E., Glantschnig H., Wesolowski G.A., Gentile M.A., Fisher J.E., Rodan G.A., et al. Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 2004, 11(Suppl 1):S108-S118.
59. Hoofnagle A.N., Vaisar T., Mitra P., Chait A. HDL lipids and insulin resistance. Curr Diab Rep 2010, 10:78-86.
60. Tikkanen M.J., Vihma V., Jauhiainen M., Hockerstedt A., Helisten H., Kaamanen M. Lipoprotein-associated estrogens. Cardiovasc Res 2002, 56:184-188.
61. Badeau R.M., Metso J., Tikkanen M.J., Jauhiainen M. High-density lipoprotein-associated 17beta-estradiol fatty acyl ester uptake by Fu5AH hepatoma cells: implications of the roles of scavenger receptor class B, type I and the low-density lipoprotein receptor. Biochim Biophys Acta 2007, 1771:1329-1334.
62. Erkkila A.T., Lichtenstein A.H., Dolnikowski G.G., Grusak M.A., Jalbert S.M., Aquino K.A., et al. Plasma transport of vitamin K in men using deuterium-labeled collard greens. Metabolism 2004, 53:215-221.
63. Soeta S., Higuchi M., Yoshimura I., Itoh R., Kimura N., Aamsaki H. Effects of vitamin E on the osteoblast differentiation. J Vet Med Sci 2010, 72:951-957.
64. Atkins G.J., Welldon K.J., Wijenayaka A.R., Bonewald L.F., Findlay D.M. Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms. Am J Physiol Cell Physiol 2009, 297:C1358-C1367.
65. Wagner G.P., Zhang J. The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms. Nat Rev Genet 2011, 12:204-213.
66. Karasik D., Kiel D.P. Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone 2010, 46:1226-1237.
67. Paigen B. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 1995, 62:458S-462S.
68. Korstanje R., Paigen B. From QTL to gene: the harvest begins. Nat Genet 2002, 31:235-236.
69. Sen S., Churchill G.A. A statistical framework for quantitative trait mapping. Genetics 2001, 159:371-387.
70. Ackert-Bicknell C.L., Karasik D., Li Q., Smith R.V., Hsu Y.H., Churchill G.A., et al. Mouse BMD quantitative trait loci show improved concordance with human genome-wide association loci when recalculated on a new, common mouse genetic map. J Bone Miner Res 2010, 25:1808-1820.
71. Su Z., Korstanje R., Tsaih S.W., Paigen B. Candidate genes for obesity revealed from a C57BL/6J×129S1/SvImJ intercross. Int J Obes (Lond) 2008, 32:1180-1189.
72. Su Z., Ishimori N., Chen Y., Leiter E.H., Churchill G.A., Paigen B., et al. Four additional mouse crosses improve the lipid QTL landscape and identify Lipg as a QTL gene. J Lipid Res 2009, 50:2083-2094.
73. Stylianou I.M., Tsaih S.W., DiPetrillo K., Ishimori N., Li R., Paigen B., et al. Complex genetic architecture revealed by analysis of high-density lipoprotein cholesterol in chromosome substitution strains and F2 crosses. Genetics 2006, 174:999-1007.
74. Wergedal J.E., Ackert-Bicknell C.L., Beamer W.G., Mohan S., Baylink D.J., Srivastava A.K. Mapping genetic loci that regulate lipid levels in a NZB/B1NJxRF/J intercross and a combined intercross involving NZB/B1NJ, RF/J, MRL/MpJ, and SJL/J mouse strains. J Lipid Res 2007, 48:1724-1734.
75. Brockmann G.A., Karatayli E., Neuschl C., Stylianou I.M., Aksu S., Ludwig A., et al. Genetic control of lipids in the mouse cross DU6i×DBA/2. Mamm Genome 2007, 18:757-766.
76. Wang S.S., Shi W., Wang X., Velky L., Greenlee S., Wang M.T., et al. Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice. Arterioscler Thromb Vasc Biol 2007, 27:2671-2676.
77. Stylianou I.M., Langley S.R., Walsh K., Chen Y., Revenu C., Paigen B. Differences in DBA/1J and DBA/2J reveal lipid QTL genes. J Lipid Res 2008, 49:2402-2413.
78. Wang X., Paigen B. Genetics of variation in HDL cholesterol in humans and mice. Circ Res 2005, 96:27-42.
79. Schilling A.F., Schinke T., Munch C., Gebauer M., Niemeier A., Priemel M., et al. Increased bone formation in mice lacking apolipoprotein E. J Bone Miner Res 2005, 20:274-282.
80. Xiao Q., Danton M.J., Witte D.P., Kowala M.C., Valentine M.T., Bugge T.H., et al. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc Natl Acad Sci U S A 1997, 94:10335-10340.
81. Boes E., Coassin S., Kollerits B., Heid I.M., Kronenberg F. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol 2009, 44:136-160.
82. Ma L., Yang J., Runesha H.B., Tanaka T., Ferrucci L., Bandinelli S., et al. Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data. BMC Med Genet 2010, 11:55.
83. Thomas D. Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health 2010, 31:21-36.
84. Stearns F.W. One hundred years of pleiotropy: a retrospective. Genetics 2010, 186:767-773.
85. Wittenburg H., Lyons M.A., Li R., Kurtz U., Wang X., Mossner J., et al. QTL mapping for genetic determinants of lipoprotein cholesterol levels in combined crosses of inbred mouse strains. J Lipid Res 2006, 47:1780-1790.
86. Guan Y., Ackert-Bicknell C.L., Kell B., Troyanskaya O.G., Hibbs M.A. Functional genomics complements quantitative genetics in identifying disease-gene associations. PLoS Comput Biol 2010, 6:e1000991.
87. Junyent M., Tucker K.L., Smith C.E., Lane J.M., Mattei J., Lai C.Q., et al. The effects of ABCG5/G8 polymorphisms on HDL-cholesterol concentrations depend on ABCA1 genetic variants in the Boston Puerto Rican Health Study. Nutr Metab Cardiovasc Dis 2010, 20:558-566.
88. Junyent M., Tucker K.L., Smith C.E., Garcia-Rios A., Mattei J., Lai C.Q., et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res 2009, 50:565-573.
89. Long J.R., Liu P.Y., Liu Y.J., Lu Y., Shen H., Zhao L.J., et al. APOE haplotypes influence bone mineral density in Caucasian males but not females. Calcif Tissue Int 2004, 75:299-304.
90. Peter I., Crosier M.D., Yoshida M., Booth S.L., Cupples L.A., Dawson-Hughes B., et al. Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis. Osteoporos Int 2010, 22:1199-1209.
91. Schoofs M.W., van der Klift M., Hofman A., van Duijn C.M., Stricker B.H., Pols H.A., et al. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study. J Bone Miner Res 2004, 19:1490-1496.
92. Singh M., Singh P., Singh S., Juneja P.K., Kaur T. A susceptible haplotype within APOE gene influences BMD and intensifies the osteoporosis risk in postmenopausal women of Northwest India. Maturitas 2010, 67:239-244.
93. Tong T.Y., Yong R.Y., Goh V.H., Liang S., Chong A.P., Mok H.P., et al. Association between an intronic apolipoprotein E polymorphism and bone mineral density in Singaporean Chinese females. Bone 2010, 47:503-510.
94. Martin-Millan M., Almeida M., Ambrogini E., Han L., Zhao H., Weinstein R.S., et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 2010, 24:323-334.
95. McCauley L.K., Tozum T.F., Kozloff K.M., Koh-Paige A.J., Chen C., Demashkieh M., et al. Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism. Connect Tissue Res 2003, 44(Suppl 1):250-263.
96. Ohlsson C., Hellberg N., Parini P., Vidal O., Bohlooly Y.M., Rudling M., et al. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 2000, 278:640-645.
97. Abdul Shakoor S.K., Shalet S.M. Effects of GH replacement on metabolism and physical performance in GH deficient adults. J Endocrinol Invest 2003, 26:911-918.
98. Dennison E.M., Syddall H.E., Jameson K.A., Sayer A.A., Gaunt T.R., Rodriguez S., et al. A study of relationships between single nucleotide polymorphisms from the growth hormone-insulin-like growth factor axis and bone mass: the Hertfordshire cohort study. J Rheumatol 2009, 36:1520-1526.
99. Giustina A., Mazziotti G., Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008, 29:535-559.
100. Bustamante M., Nogues X., Mellibovsky L., Agueda L., Jurado S., Caceres E., et al. Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur J Endocrinol 2007, 157:677-684.
101. Yang T.L., Shen H., Xiong D.H., Xiao P., Guo Y., Guo Y.F., et al. Epistatic interactions between genomic regions containing the COL1A1 gene and genes regulating osteoclast differentiation may influence femoral neck bone mineral density. Ann Hum Genet 2007, 71:152-159.
102. Huang Q.Y., Shen H., Deng H.Y., Conway T., Davies K.M., Li J.L., et al. Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations. J Hum Genet 2003, 48:430-437.
103. Chung H.W., Seo J.S., Hur S.E., Kim H.L., Kim J.Y., Jung J.H., et al. Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet 2003, 48:243-248.
104. Ota N., Nakajima T., Nakazawa I., Suzuki T., Hosoi T., Orimo H., et al. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001, 46:267-272.
105. Deng F.Y., Long J.R., Lei S.F., Li M.X., Deng H.W. Potential effect of inter-genic action on peak bone mass (PBM) in Chinese females. Yi Chuan Xue Bao 2005, 32:1003-1010.
106. Hulkkonen J., Lehtimaki T., Mononen N., Juonala M., Hutri-Kahonen N., Taittonen L., et al. Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 2009, 203:454-458.
107. Halverstadt A., Phares D.A., Roth S., Ferrell R.E., Goldberg A.P., Hagberg J.M. Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim Biophys Acta 2005, 1734:143-151.
108. Yang X., Ricciardi B.F., Hernandez-Soria A., Shi Y., Pleshko Camacho N., Bostrom M.P. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 2007, 41:928-936.
109. Kiel D.P., Demissie S., Dupuis J., Lunetta K.L., Murabito J.M., Karasik D. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 2007, 8(Suppl. 1):S14.
110. McLean R.R., Karasik D., Selhub J., Tucker K.L., Ordovas J.M., Russo G.T., et al. Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 2004, 19:410-418.
111. Real J.T., Martinez-Hervas S., Garcia-Garcia A.B., Chaves F.J., Civera M., Ascaso J.F., et al. Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemia. J Atheroscler Thromb 2009, 16:815-820.
112. Petramala L., Acca M., Francucci C.M., D'Erasmo E. Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?. J Endocrinol Invest 2009, 32:10-14.
113. Chen Z., Karaplis A.C., Ackerman S.L., Pogribny I.P., Melnyk S., Lussier-Cacan S., et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001, 10:433-443.
114. Kim B.J., Kim S.Y., Cho Y.S., Han B.G., Park E.K., Lee S.H., et al. Association of Paraoxonase 1 (PON1) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women. Exp Mol Med 2011, 43:71-81.
115. Yamada Y., Ando F., Niino N., Miki T., Shimokata H. Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese. J Hum Genet 2003, 48:469-475.
116. Akune T., Ohba S., Kamekura S., Yamaguchi M., Chung U.-i., Kubota N., et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004, 113:846-855.
117. Brand-Herrmann S.M., Kuznetsova T., Wiechert A., Stolarz K., Tikhonoff V., Schmidt-Petersen K., et al. Alcohol intake modulates the genetic association between HDL cholesterol and the PPARgamma2 Pro12Ala polymorphism. J Lipid Res 2005, 46:913-919.
118. Ereqat S., Nasereddin A., Azmi K., Abdeen Z., Amin R. Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients. PPAR Res 2009, 2009:874126.
119. Rhee E.J., Oh K.W., Lee W.Y., Kim S.Y., Oh E.S., Baek K.H., et al. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome. Arch Med Res 2006, 37:86-94.
120. Tai E.S., Corella D., Deurenberg-Yap M., Adiconis X., Chew S.K., Tan C.E., et al. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res 2004, 45:674-685.
121. Yang L.L., Hua Q., Liu R.K., Yang Z. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population. Arch Med Res 2009, 40:89-96.
122. Furuta I., Kobayashi N., Fujino T., Kobamatsu Y., Shirogane T., Yaegashi M., et al. Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women. Calcif Tissue Int 2004, 74:509-515.
123. Fontova R., Gutierrez C., Vendrell J., Broch M., Vendrell I., Simon I., et al. Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-alpha gene polymorphisms in post-menopausal Mediterranean women. J Endocrinol Invest 2002, 25:684-690.
124. Wennberg P., Nordstrom P., Lorentzon R., Lerner U.H., Lorentzon M. TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol 2002, 146:629-634.
125. Fontaine-Bisson B., El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. J Nutrigenet Nutrigenomics 2008, 1:215-223.
126. Parra-Rojas I., Ruiz-Madrigal B., Martinez-Lopez E., Panduro A. Influence of the -308 TNF-alpha and -174 IL-6 polymorphisms on lipid profile in Mexican subjects. Hereditas 2006, 143:167-172.
127. Li Y., Li A., Strait K., Zhang H., Nanes M.S., Weitzmann M.N. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res 2007, 22:646-655.